Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.
about
Identification of the TCL1 gene involved in T-cell malignanciesExpression, regulation, and chromosomal localization of the Max geneIdentification of a single chromosome in the normal human genome essential for suppression of hamster cell transformationThe (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34MYC oncogene involved in a t(8;22) chromosome translocation is not altered in its putative regulatory regionsInvolvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanomaChromosomal orientation of the lambda light chain locus: V lambda is proximal to C lambda in 22q11Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not alteredEpstein-Barr virus and Burkitt lymphomaCloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocationThe transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphomaN-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genesMYC association with cancer risk and a new model of MYC-mediated repression.The first exon of the c-myc proto-oncogene contains a novel positive control element.Chromatin structure of transcriptionally active and inactive human c-myc allelesMapping of the c-myc, pvt-1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma-associated variant (6;15) translocation breakpoint.Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-livesSequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.Translocation of an immunoglobulin kappa locus to a region 3' of an unrearranged c-myc oncogene enhances c-myc transcription.The molecular biology of chromosome alterations in myelogenous leukemia.Characterization of proopiomelanocortin transcripts in human nonpituitary tissuesChanges in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.Our changing view of the genomic landscape of cancer.Regulation of translocated c-myc genes transfected into plasmacytoma cells.A translocated human c-myc oncogene is altered in a conserved coding sequenceAnalysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphomaStrong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoterAnalysis of the 3' flanking region of the human c-myc gene in lymphomas with the t(8;22) and t(2;8) chromosomal translocationsTranslocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus.Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations.Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomasMolecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Saccharomyces cerevisiae: comparison of the protein products.MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus.Opposite replication polarity of the germ line c-myc gene in HeLa cells compared with that of two Burkitt lymphoma cell linesTwo distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells.Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
P2860
Q24336607-41F1CDA7-BEFC-4895-8D70-AEFDE9E89810Q24562145-C527DFAC-B449-42CA-AB1B-95ED13F6AA04Q24568213-9B331AA6-00B5-40E6-A26F-CA52EA7282D8Q24598594-290EF16D-3FFF-4635-B644-736CDB28A543Q24611746-85D2069D-64C0-4EDB-805E-85C8D09794EBQ24612665-9BFB01DE-CC25-4411-8068-B1003F1FEBDCQ24625551-E5DE6476-0F8D-4699-9E29-99E1D0A57B90Q24651262-6AF7F03B-62E9-4BB3-AFB4-850983F6E141Q24669890-E99219C6-1C75-4888-86B7-44E065C84BE7Q24675000-7D236FCD-6879-4351-B56D-39545A2F0884Q28302430-ACB120D7-21F8-40E0-9B9F-3640C0D60EEFQ33561040-E9A1070F-CF84-4A4D-9193-96B2B9388B78Q33781322-B8EE7F77-592E-44CB-8EDE-61BAAD587E4EQ33790662-D32112A8-0DEC-47DA-BCEA-5A7A05AF54DBQ33881231-7464C2C3-C5D5-4AB7-90ED-081D88215ABDQ33931872-FF28E964-4018-4F2F-A99B-6E34BE582119Q33932000-94F2146D-3424-4E8A-86C9-2E1BC0B86836Q33932184-B8631C8B-344D-4531-80E1-9E2E6431E0D4Q33934166-D76D0E1B-24FC-406A-BE43-86803ABB82A3Q34055693-EFB00A45-9C2D-457F-BE0D-90A70659CE64Q34193213-32910CB8-B354-4187-BA78-5D6CE5435632Q34354934-C6B710C4-00F4-402B-88E5-08E955A16439Q34534394-EEEF426F-DDDE-4E5E-85D0-70EE970F05F7Q35368205-9CB9D15E-3F00-453F-A79B-B21DB6904CBCQ35588621-8F85A8F7-E012-48CF-ADED-547B1CE43E20Q35602831-E20CA8D4-C3FD-4520-8E88-034D40066ED0Q35617276-926414C6-23D2-491C-88F9-FACEDA5F3020Q35939969-47FF8BF1-A7E7-456F-8E49-AB49E16CE277Q36099554-74BF784F-9A85-4D64-AB16-9050EAF7F29BQ36261532-86C21ACB-E413-4041-B65F-9ABDDD78E366Q36264870-79658513-C8C8-487A-B61C-A0D149249BFFQ36270502-9F5C3DE3-8FF0-4F0C-9F48-701629795AADQ36410698-3FE05D21-214E-4093-BEE0-D326D2BBCF9DQ36489739-1775A82F-8167-435D-BF77-8D6283839456Q36545376-3213B995-953E-4950-9D46-06BC7F8952F5Q36598671-ED8790A5-A332-4009-A968-4DFA4C43689BQ36766007-8138310C-1924-44B8-AECB-D4A851FFC27FQ36783817-427F55AF-44E5-45C2-A047-431A125B1435Q36838691-D326FC70-F13E-458A-9431-BB55BFCA6402Q36850030-74778C2C-8FE8-44D2-AD69-D2BE531ACEF0
P2860
Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential expression of the ...... an c-myc oncogenes in B cells.
@en
Differential expression of the ...... an c-myc oncogenes in B cells.
@nl
type
label
Differential expression of the ...... an c-myc oncogenes in B cells.
@en
Differential expression of the ...... an c-myc oncogenes in B cells.
@nl
prefLabel
Differential expression of the ...... an c-myc oncogenes in B cells.
@en
Differential expression of the ...... an c-myc oncogenes in B cells.
@nl
P2093
P2860
P356
P1476
Differential expression of the ...... an c-myc oncogenes in B cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.15.4822
P407
P577
1983-08-01T00:00:00Z